SAN ANTONIO, Texas, April 18, 2006 (SEND2PRESS NEWSWIRE) -- Dr. Anthony P. Sertich II of San Antonio, Texas is one of the first physicians in Texas to offer a new, minimally invasive technology for treating chronic sinus inflammation. The Balloon Sinuplasty(TM) system uses a small catheter and balloon to quickly open and expand blocked sinuses. To date Dr. Sertich has treated over 40 individuals successfully, and many more are in line to receive the balloon sinuplasty procedure.
Sinusitis is one of the most common chronic health problems in the U.S., afflicting 37 million Americans each year. Patients suffer headaches, congestion, fatigue and other symptoms. This condition significantly impacts an individual's physical, functional, and emotional quality of life.
Until recently, sinusitis patients were limited to two treatment options: medical therapy such as antibiotics and topical nasal steroids, and for more severe situations, a conventional sinus surgery such as Functional Endoscopic Sinus Surgery (FESS). However, FESS is a surgery that requires bone and tissue removal in order to open up blocked sinus passageways. With the possibility for complications and the typically long recovery times, patients often opted to continue their own personal suffering.
Now, with the Balloon Sinuplasty(TM) technology, patients have a viable alternative. A small, flexible balloon catheter is placed through a nostril into the blocked sinus passageway. The balloon is then inflated to gently restructure and open the sinus passageway, restoring normal sinus drainage and function.
In performing the balloon sinuplasty procedure, Dr. Sertich has been able to offer this minimally invasive alternative to patients who may fear extensive surgery that could result in complications and long recovery periods. Balloon sinuplasty makes it possible to achieve faster recovery times and less post-procedure discomfort. In fact, many of his patients have been able to return to normal activities within 24 hours and have had significant improvement in their symptoms.
About Dr. Sertich:
A native of San Antonio, Texas, Dr. Anthony Sertich received his Bachelor of Arts with highest honors from St. Mary's University in San Antonio and his Medical Degree from the University of Texas, Southwestern Medical School, at Dallas. After completing his residency in general surgery, otolaryngology and head and neck facial plastic surgery at the University of South Florida in Tampa, Florida, he returned to San Antonio to begin his private practice.
He established the South Texas Otorhinolaryngology Facial Plastic Head and Neck Surgery Associates with his diverse interests in adult and pediatric disorders of the ear, nose, and throat, with special experience and training in facial plastic surgery.
Dr. Anthony Sertich is Board certified by the American Board of Otolaryngology, Head and Neck Surgery; A Fellow of the American College of Surgeons; a Fellow member of the American Academy of Facial Plastic and Reconstructive Surgery; Assistant Clinical Professor for the Department of Otolaryngology, Head and Neck Surgery at the University of Texas Health Science Center at San Antonio; past President of the San Antonio Otolaryngology, Head and Neck Surgery Society; a Fellow member of American Academy Otolaryngology - Head and Neck Surgery; and past chief of the section of Otolaryngology, Head and Neck Surgery at the Southwest Texas Methodist Hospital in San Antonio.
Sinusitis patients who reside in Texas and are considering their options can learn more about the Balloon Sinuplasty(TM) technology by contacting Dr. Sertich's office at 210-614-8625, or by visiting http://www.sertichmd.com.
** This is archival content and may no longer be valid.
New Technology in Treating Chronic Sinus Infections Performed in Texas by San Antonio Physician
Rights granted for reproduction by any legitimate news organization. However, if news is cloned/scraped verbatim, then original attribution must be maintained with link back to this page as “original syndication source.” Resale of this content for commercial purposes is prohibited without a license. Reproduction on any site selling a competitive service is also prohibited. Information is believed accurate, as provided by news source or authorized agency, however is not guaranteed, and you assume all risk for use of any information found herein/hereupon. This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License.
[ count retired 8.4.16 ]
back to top